Skip to main content
Previous Poster Home Next

Evaluating the Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in patients with Breast and Non-Small Cell Lung Cancer (NSCLC)
07:30am - 03:45pm EST - March 31, 2023

  • Information
  • Resources
  • Play Recording

Evaluating the Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in patients with Breast and Non-Small Cell Lung Cancer (NSCLC) icon

https://jnccn.org/view/journal...


Author(s):
  • Mr. Mason Alford, MSc, Medical Student, Vanderbilt School of Medicine

Tags: Member Institution Clinical Oncology

Display Label Action
Alford NCCN Poster.pdf Download Handout
AC23P17 - Evaluating the Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in patients with Breast and Non-Small Cell Lung Cancer (NSCLC) Download MP3